Laurion Capital Management LP Has Cut Horizon Pharma Plc (Put) (HZNP) Position By $2.75 Million; 8 Analysts Covering Freshpet, Inc. (FRPT)

December 7, 2017 - By Michael Collier

Among 14 analysts covering Freshpet Inc (NASDAQ:FRPT), 8 have Buy rating, 0 Sell and 6 Hold. Therefore 57% are positive. Freshpet Inc had 27 analyst reports since August 13, 2015 according to SRatingsIntel. William Blair initiated the shares of FRPT in report on Thursday, August 13 with “Outperform” rating. The firm earned “Buy” rating on Tuesday, January 19 by Canaccord Genuity. The stock of Freshpet, Inc. (NASDAQ:FRPT) has “Outperform” rating given on Tuesday, November 10 by Wedbush. The rating was downgraded by Credit Suisse to “Neutral” on Thursday, November 12. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, June 23 report. Credit Suisse maintained Freshpet, Inc. (NASDAQ:FRPT) on Tuesday, November 7 with “Neutral” rating. Robert W. Baird maintained the stock with “Buy” rating in Friday, October 13 report. The company was initiated on Wednesday, October 5 by DA Davidson. The rating was maintained by Robert W. Baird on Wednesday, September 6 with “Buy”. On Thursday, November 12 the stock rating was maintained by Suntrust Robinson with “Buy”. See Freshpet, Inc. (NASDAQ:FRPT) latest ratings:

15/11/2017 Broker: Robert W. Baird Rating: Buy New Target: $20.0 Maintain
07/11/2017 Broker: Credit Suisse Rating: Neutral Old Target: $15 New Target: $17 Maintain
13/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $20.0 Maintain
02/10/2017 Broker: Susquehanna Rating: Hold New Target: $15.0
18/09/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $20.0 Maintain
06/09/2017 Broker: Robert W. Baird Rating: Buy New Target: $20.0 Maintain
08/08/2017 Broker: SunTrust Rating: Buy New Target: $20.0000
07/08/2017 Broker: Oppenheimer Rating: Hold Maintain
20/07/2017 Broker: Imperial Capital Rating: In-Line New Target: $16.5 Initiates Coverage On
23/06/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $14.0000 Maintain

Laurion Capital Management Lp decreased Horizon Pharma Plc (Put) (HZNP) stake by 50% reported in 2017Q2 SEC filing. Laurion Capital Management Lp sold 250,000 shares as Horizon Pharma Plc (Put) (HZNP)’s stock declined 38.11%. The Laurion Capital Management Lp holds 250,000 shares with $2.97 million value, down from 500,000 last quarter. Horizon Pharma Plc (Put) now has $2.39B valuation. The stock increased 0.76% or $0.11 during the last trading session, reaching $14.59. About 155,625 shares traded. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 28.13% since December 7, 2016 and is downtrending. It has underperformed by 44.83% the S&P500.

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Horizon Pharma had 53 analyst reports since September 9, 2015 according to SRatingsIntel. Jefferies reinitiated the shares of HZNP in report on Monday, November 23 with “Buy” rating. Mizuho maintained it with “Buy” rating and $30 target in Tuesday, November 8 report. The firm earned “Buy” rating on Tuesday, May 10 by Mizuho. On Tuesday, May 9 the stock rating was downgraded by Mizuho to “Neutral”. The firm has “Buy” rating by Goldman Sachs given on Monday, June 6. The stock has “Buy” rating by Piper Jaffray on Monday, August 7. Jefferies maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Tuesday, August 8 with “Buy” rating. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) has “Buy” rating given on Tuesday, May 3 by Mizuho. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Buy” rating by Piper Jaffray on Friday, July 14. The stock has “Buy” rating by UBS on Thursday, November 30.

Laurion Capital Management Lp increased 3M Co (Call) (NYSE:MMM) stake by 67,900 shares to 93,400 valued at $19.45 million in 2017Q2. It also upped Vornado Rlty Tr (NYSE:VNO) stake by 21,000 shares and now owns 28,000 shares. Verizon Communications Inc (Put) (NYSE:VZ) was raised too.

Investors sentiment decreased to 0.92 in Q2 2017. Its down 0.10, from 1.02 in 2017Q1. It worsened, as 43 investors sold HZNP shares while 52 reduced holdings. 34 funds opened positions while 53 raised stakes. 130.94 million shares or 1.72% less from 133.24 million shares in 2017Q1 were reported. 457,780 were reported by Tiaa Cref Investment Mngmt Ltd Llc. Rmb Mgmt Limited Liability Corporation holds 0.03% or 100,033 shares in its portfolio. Jpmorgan Chase & holds 0.01% or 3.83 million shares in its portfolio. 125,933 were accumulated by Manufacturers Life Insurance The. Proxima Capital Management Limited holds 266,311 shares or 1.71% of its portfolio. Highbridge Management Ltd Liability Co stated it has 0.05% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Panagora Asset Management holds 239,513 shares or 0.01% of its portfolio. 108,994 are owned by Nuveen Asset Management Limited Liability Company. Davidson Invest Advisors owns 225 shares for 0% of their portfolio. Moody Bank Division stated it has 0.01% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Malaga Cove Ltd Liability Co reported 0.36% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Goldman Sachs Gp holds 2.16M shares. 1.48 million were accumulated by Rothschild Asset Mngmt Inc. Prudential Public Limited Liability has 339,296 shares for 0.01% of their portfolio. Bnp Paribas Arbitrage Sa has invested 0% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP).

Analysts await Horizon Pharma Public Limited Company (NASDAQ:HZNP) to report earnings on February, 26. They expect $0.22 earnings per share, down 56.00% or $0.28 from last year’s $0.5 per share. HZNP’s profit will be $36.05 million for 16.58 P/E if the $0.22 EPS becomes a reality. After $0.26 actual earnings per share reported by Horizon Pharma Public Limited Company for the previous quarter, Wall Street now forecasts -15.38% negative EPS growth.

The stock increased 0.20% or $0.04 during the last trading session, reaching $18.99. About 4,170 shares traded. Freshpet, Inc. (NASDAQ:FRPT) has risen 61.82% since December 7, 2016 and is uptrending. It has outperformed by 45.12% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Michael Collier




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: